The Europe aseptic connectors market was valued at $198.8 million in 2023 and is expected to reach $472.9 million by 2033, growing at a CAGR of 9.05% between 2023 and 2033.
The Europe HPLC market was estimated at $1,269.2 million in 2023 and is expected to reach $2,014.3 million by 2033, growing at a CAGR of 4.73% during the forecast period 2023-2033.
The Asia-Pacific continuous bioprocessing market was valued at $51.0 million in 2023 and is expected to reach $388.5 million by 2033, growing at a CAGR of 22.50% between 2023 and 2033.
In an optimistic scenario, the market, valued at $8.7 million in 2024, is anticipated to grow at a CAGR of 15.43%, reaching $36.7 million by 2034.
The Asia-Pacific protein expression market was valued at $530.6 million in 2023 and is expected to reach $1,809.8 million by 2033, growing at a CAGR of 13.05% between 2023 and 2033.
Need reports on an on-going basis? Do consider our annual subscription
The global mass spectrometry and chromatography in diagnostics market was valued at $743.1 million in 2023 and is expected to reach $1,863.8 million by 2033, growing at a CAGR of 9.92% during the forecast period 2024-2033.
The Asia-Pacific synthetic hormones market size was estimated at $2.41 billion in 2023 and is expected to reach $4.89 billion by 2033, growing at a CAGR of 7.34% during the forecast period 2023-2033.
The Europe highly potent API market is projected to reach $16.33 billion by 2033 from $5.98 billion in 2023, growing at a CAGR of 10.57% during the forecast period 2023-2033.
The Europe synthetic hormones market size was estimated at $4.90 billion in 2023 and is expected to reach $10.53 billion by 2033, growing at a CAGR of 7.94% during the forecast period 2023-2033.
Expected to grow from a base of $1.02 billion in 2024, the market is projected to experience a compound annual growth rate (CAGR) of 8.43%, reaching approximately $2.29 billion by 2034.
The global organ-on-chip market is projected to reach $3,596.3 million by 2033 from $109.9 million in 2023, growing at a CAGR of 42.09% during the forecast period 2024-2033.
The global PMS and menstrual health supplements market was valued at $21.68 billion in 2023 and is expected to reach $37.23 billion by 2033, growing at a CAGR of 5.45% between 2023 and 2033.
The global NIPT market was valued at $3,350.4 million in 2023 and is expected to reach $12,870.9 million by 2033, registering a CAGR of 14.41% during the forecast period 2023-2033.
The global HPLC market was estimated at $5.23 billion in 2023 and is expected to reach $8.22 billion by 2033, growing at a CAGR of 4.61% during the forecast period 2023-2033.
The global aseptic connectors market was valued at $746.7 million in 2023 and is expected to reach $1,907.0 million by 2033, growing at a CAGR of 9.83% between 2023 and 2033.
The global continuous bioprocessing market was valued at $250.1 million in 2023 and is expected to reach $1,639.1 million by 2033, growing at a CAGR of 20.68% between 2023 and 2033.
The Asia-Pacific cell-based assay market was valued at $4.05 billion in 2023 and is anticipated to reach $9.19 billion by 2032, witnessing a CAGR of 9.53% during the forecast period 2023-2032.
The global protein expression market was valued at $2,393.0 million in 2023 and is expected to reach $6,963.6 million by 2033, growing at a CAGR of 11.27% between 2023 and 2033.
The market size was estimated at $19.40 billion in 2023 and is expected to reach $38.08 billion by 2033, growing at a CAGR of 6.98% during the forecast period 2023-2033.
The global highly potent API market is projected to reach $84.20 billion by 2033 from $27.44 billion in 2023, growing at a CAGR of 11.86% during the forecast period 2023-2033.
The market size is anticipated to be $0.06 billion in 2026 and is expected to reach $7.72 billion by 2040, growing at a CAGR of 41.55% during the forecast period 2026-2040.
The Korea centrifugation market was valued at $46.1 million in 2023 and is expected to reach $80.6 million by 2033, growing at a CAGR of 5.75% between 2023 and 2033.
The global veterinary vaccine market is projected to reach $19.86 billion by 2033 from $9.82 billion in 2023, growing at a CAGR of 7.30% during the forecast period 2023-2033.
This report aims to provide a comprehensive analysis of the single use assemblies market, focusing on current unmet needs, trends, challenges and opportunities shaping the industry landscape.
The global bioprocess bags and containers market report offers a detailed assessment of market segments, including product type and end user, elucidating their respective market shares and growth prospects.
The bioprocessing probes and sensors market report provides a comprehensive analysis of the industry, highlighting key trends, market dynamics, and growth opportunities.
The report contains crucial statistics concerning the status of prominent players in the cystatin C assay market, highlighting key trends and potential opportunities within the market.
The global antibody therapeutic market occupies a pivotal role within the biopharmaceutical and life sciences sectors, dedicated to the manufacturing, advancement, and commercialization of antibodies with diverse applications in medical and research domains.
This report aims to provide a comprehensive analysis of the ALL market, focusing on current unmet needs, trends, challenges and opportunities shaping the industry landscape.
Global bioprocessing validation market report serves as a valuable resource for industry participants, investors, and decision-makers seeking to navigate the dynamic landscape.
The market is expected to grow at a CAGR of 15.43% during the forecast period 2023-2032 and attain a value of $80.05 billion by 2032.
The report constitutes an extensive study of GCC Veterinary Laboratories industry.
The global pharmaceutical excipients market is witnessing robust growth due to the increasing demand for pharmaceutical formulations and rising focus on drug delivery systems.
The market is expected to grow at a CAGR of 11.31% during the forecast period 2023-2033 and attain a value of $36.82 billion by 2033.
The market's expansion is driven by factors such as increasing incidence of cancer, continuous technological advancements such as the development of MRI linear accelerators, proton therapy, and the introduction of treatment planning software that integrates with imaging data.
The Europe biomanufacturing viral detection and quantification market was valued at $137.3 million in 2022 and is anticipated to reach $345.9 million by 2032.
The Asia-Pacific cell and gene therapy biomanufacturing market was valued at $1.96 billion in 2022 and is expected to reach $8.60 billion by the end of 2031, growing at a CAGR of 17.88% during the forecast period 2022-2031.
Asia-Pacific nucleic acid therapeutics CDMO market was valued at $0.97 billion in 2022 and is expected to reach $4.04 billion by 2033.
The global cell and gene therapy biomanufacturing CDMO market - focused on AAV was valued at $231.3 million in 2022 and is anticipated to reach $2,566.6 million by 2033, witnessing a CAGR of 24.61% during the forecast period 2023-2033.
The global biomanufacturing viral detection and quantification market was valued at $474.3 million in 2022 and is anticipated to reach $1,149.7 million by 2032, witnessing a CAGR of 9.37% during the forecast period 2023-2032.
The global constrained peptide drugs market is expected to reach $17.38 billion in 2040 from $0.06 billion in 2024, growing at a CAGR of 38.94% during the forecast period 2025-2040.
The global gene editing technologies market was valued at $1.81 billion in 2022 and is anticipated to reach $16.37 billion by 2032, witnessing a CAGR of 27.50% during the forecast period 2023-2032.
The global cell-based assay market is expected to reach $38.23 billion in 2032 from $17.20 billion in 2022, at a CAGR of 8.44% during the forecast period 2023-2032.
The global nucleic acid therapeutics CDMO market was valued at $3.88 billion in 2022 and is expected to reach $14.19 billion by 2033, growing at a CAGR of 12.55% during the forecast period 2023-2033.
The global cell and gene therapy biomanufacturing market was valued at $12.31 billion in 2022 and is anticipated to reach $29.76 billion by 2031, witnessing a CAGR of 10.31% during the forecast period 2022-2031.
The report focuses solely on the extensive stage small cell lung cancer treatment, which includes approved products as well as products under clinical development.
The global phosphoramidite market is projected to reach $2,062.9 million by 2032 from $900.3 million in 2021, at a CAGR of 7.78% during the forecast period 2022-2032.
In 2021, the global 3D protein structure analysis market was valued at $1,017.2 million, and it is expected to reach $2,676.6 million by 2032, growing at a CAGR of 9.32% during the forecast period 2022-2032.
The global market for serum-free media was valued at $1,022.4 million in 2021 and is expected to reach $3,920.5 million by 2032, registering a CAGR of 12.73% during the forecast period 2022-2032.
The report provides an exhaustive list of pipeline products which are currently in the development along with their developmental details in various indications.
The global FLT3 inhibitors market is expected to reach $2,061.3 million in 2032 from $400.9 million in 2021 at a CAGR of 14.88% during the forecast period 2022-2032.
The global pharmaceutical aseptic transfer market is projected to reach $2,551.5 million by 2031 from $855.2 million in 2021 at a CAGR of 9.61% during the forecast period 2022-2031.
The global narcolepsy therapeutics market is projected to reach $4,912.3 million by 2032 from $915.2 million in 2021 at a CAGR of 15.93% during the forecast period 2022-2032.
The global ligase market is projected to reach $651.4 million by 2032 from $371.2 million in 2021, at a CAGR of 5.29% during the forecast period 2022-2032.
In 2021, the global microbiome therapeutics market valued $306.3 million, and it is estimated to reach $3,204 million by 2032, registering a CAGR of 24.95% during the forecast period 2022-2032.
The global NK cell therapeutics market is expected to reach $5,676.1 million in 2032 from $297.2 million in 2024 at a CAGR of 44.59% during the forecast period 2024-2032.
In 2021, the global axial spondyloarthritis market was valued at $1,873.8, which is expected to reach $7,937.8 million in 2032 by witnessing a growing CAGR of 13.44% during the forecast period, 2022-2032.
The global blood and plasma components market is projected to reach $66.47 billion in 2031 from $39.58 billion in 2020, witnessing a CAGR of 4.90% during the forecast period 2021-2031.
The global radioligand therapy market is projected to reach $16,658.4 million by 2031, growing from $9,754.9 million in 2020, at a CAGR of 4.67% during the forecast period 2021-2031.
In 2020, the global hematological malignancies emerging therapeutics market was valued at $8,444.8 million, which is expected to reach $43,966.8 million in 2031.
The global aseptic pharma processing market was valued to be $10,633.3 million in 2020 and is expected to reach $24,364.0 million by 2031, witnessing a CAGR of 7.90% during the forecast period 2021-2031.
The global NIPT market was valued at $2.52 billion in 2020 and is expected to reach $12.61 billion by 2031, registering a CAGR of 15.79% during the forecast period 2021-2031.
The global viral and non-viral vector manufacturing market was valued at $1.50 billion in 2020 and is expected to reach $27.03 billion by 2031, witnessing a CAGR of 18.54% during the forecast period 2021-2031.
The global CRISPR gene editing market was valued at $1,088.6 million in 2020 and is expected to reach $18,856.6 million by 2031, witnessing a CAGR of 29.60% during the forecast period 2021-2031.
The global next-generation biomanufacturing market is expected to grow at a CAGR of 14.85% during the forecast period 2021-2031 and is expected to reach a value of $85,201.2 million in 2031.
The global constrained peptide drugs market is anticipated to be valued at $60.1 million in 2023 and is expected to reach $10,367.2 million by 2031, witnessing a CAGR of 90.37% during the forecast period 2023-2031.
The global imaging CRO market is expected to grow at a CAGR of 7.25% during the forecast period 2021-2031 and is expected to reach a value of $9,603.0 million in 2031.
The global nucleic acid therapeutics CDMO market was valued at $1,546.4 million in FY2020 and is estimated to reach $4,463.7 million by 2030.
The global market for aseptic pharma processing equipment is predicted to grow at a CAGR of 7.29% over the forecast period 2021-2030.
The global market for in-vitro fertilization is predicted to grow at a CAGR of 9.37% over the forecast period 2020-2030.
The global SERD therapeutics market was valued at $1000.2 million in 2019 and is expected to reach $4085.0 million by 2030.
The global cell and gene therapy drug delivery devices market was valued at $55.75 thousand in 2019, and is expected to reach $375.13 thousand by 2030.
The global industrial microbiology market was valued to be $5,604.2 million in 2019 and is expected to reach $13,181.2 million by 2030.
The global market for microbiome therapeutics is predicted to grow at a CAGR of 25.64% over the forecast period of 2020-2030.
The global bioengineered skin substitutes market was valued at $1.31 billion in 2019 and is expected to reach $4.33 billion by 2030.
The global market for CAR T-cell therapy is predicted to grow at a CAGR of 44.79% over the forecast period 2020-2030.
The global market for autoimmune disorder drug delivery devices is predicted to grow at a CAGR of 15.25% over the forecast period of 2020-2030.
The global market for neurodegenerative disorder therapeutics is predicted to grow at a CAGR of 7.21% over the forecast period of 2020-2030.
By volume, global NIPT market was 3.14 million units in 2019 and is expected to reach 23.58 million units by 2030.
The global market for PD-1/PD-L1 immunotherapy is predicted to grow at a CAGR of 10.72% over the forecast period of 2020-2030.
The global market for IVD is predicted to grow at a CAGR of 5.06% over the forecast period of 2020-2030.
The global market for infectious disease biomarker testing market is predicted to grow at a CAGR of 14.48% during the forecast period of 2020-2030.
In 2019, the market size of the global tumor genomics market was valued at $8,131.0 million, and is expected to reach $16,287.2 million in 2028, registering a CAGR of 8.09% during the forecast period between 2020-2028.
Global Viral Vector and Plasmid Manufacturing Market to Reach $5.86 Billion by 2030.
The Global Next-Generation Biomanufacturing Market Report by BIS Research projects the market to grow at a significant CAGR of 10% during the forecast period, 2019-2029.
The global hematology testing market was valued to be $4.54 billion in 2018 and is anticipated to witness an impressive single-digit growth rate, to reach $XX billion by 2029.
The North America cannabis industry analysis by BIS Research highlights that the market was valued at $13.21 billion in 2018 and is expected to reach $36.7 billion in 2025.
The Asia-Pacific IVF market is valued at $6.99 billion in 2018, and is expected to witness a CAGR of 10.13% during the forecast period between 2019 and 2029.
The global sports medicine market was estimated to be $5.99 billion in 2018 and is expected to be $9.25 billion by 2026. It is expected to grow at a CAGR of 5.64% from 2019 to 2026.
The global human microbiome modulators market has been witnessing a steady annual growth rate of approximately 6.08% in past three years (2015-2017), and the market is expected to continue to grow with a double digit CAGR of 16.29% during the forecast period, 2018-2023.
The global vaccine market is anticipated to reach $103.57 billion by 2028, witnessing a CAGR of 11.02% in the forecast period 2018-2028.
The global nanopharmaceutical drug market is valued $40.37 billion in 2017 and is expected to reach $79.29 billion by 2026.
The global enzymes market was valued $6.57 billion in 2017 and is anticipated to reach $10.63 billion by 2025.
The global biosensors market was valued at $1.46 billion in 2017 and is anticipated to reach $3.90 billion in 2027, registering a CAGR of 10.34% in the forecast period 2018-2027..
The global CRISPR technology market is expected to reach $10.55 billion by 2027.
The global women’s health market was estimated at $30.88 billion in 2016 and is estimated to grow over $42.12 billion by 2023. The rising geriatric population among women leading to higher incidence rate of menopause and related diseases is the major factor driving the growth of the market.
The pharmaceuticals and biotechnology as well as food and beverages industry are the largest end users in industrial microbiology market due to increasing drug development, growing demand of pathogen testing in food products and increase in significance of industrial food and safety.
The global biologics drug discovery market was estimated to be $8.9 billion in 2016 and is estimated to grow over $22.7 billion by 2025. Introduction of targeted therapies coupled with rising adoption of patient centric personalized medicine is expected to fuel the demand for biologics drugs in the future.
The global biologics market generated a revenue of $238.8 billion in 2016. Introduction of targeted therapies coupled with rising adoption of patient centric personalized medicine is expected to fuel the demand for biologics drugs in the future.
The global GERD drugs market has a low growth potential in future and will account to $5.38 billion by 2023. Due to side effects of drugs on long term use, patients who fail to respond to medication & the availability of new technology, the device market is set to grow in future.
IVD is expected to increase to $76 billion by 2023 and increase its influence over healthcare spending globally. The category’s rate of growth is accelerating due to a number of key macro forces, such as demand from emerging economies, aging population, evolving clinician attitudes, and a much needed push towards theranostics and personalized medicine.
The global IVF market includes pre-treatment drugs and lab equipment, instrument & reagents. In this report the pre-treatment drugs market is not taken into consideration. The global market is expected to grow over $26.08 billion by 2022. IVF Market can be further divided into various segments and sub-segments.
Softgel capsules are a preferred dosage form for liquid or semi-solid substances, offering several benefits including ease of swallowing, precise dosing, improved bioavailability, and protection of sensitive ingredients from environmental degradation.
The global specialty excipients for parenteral pharmaceuticals market is witnessing significant growth, driven by increasing demand for advanced drug delivery systems, particularly for biologics and complex formulations.
The empty capsules are primarily used for encapsulating powdered and granular substances. These capsules, typically made from gelatin or vegetable-based materials, offer an effective delivery system for medications, vitamins, and other supplements.
The global excipients market for topical pharmaceuticals is growing, driven by demand for effective dermatological treatments and cosmeceuticals.
The liquid-filled capsules market is rapidly evolving, characterized by the growing preference for innovative delivery systems in the pharmaceutical and nutraceutical sectors.
The Hybrid Medicine market is quickly gaining traction as healthcare providers increasingly look to combine conventional treatments with alternative therapies for more comprehensive patient care.
The Cell Line Characterization Market Report provides a comprehensive analysis of the global market, offering valuable insights into the trends, and future prospects of the industry.
The global next-generation contraceptives market report provides a comprehensive analysis of the industry, offering insights into key market trends, growth drivers, challenges, and opportunities, and forecasts that a decision-maker can take advantage of.
The Antibody Hit Generation and Screening Market report covers key segments, competitive landscape, and emerging technologies, offering stakeholders a holistic view of the global market.
The global NIPT market was valued at $2.52 billion in 2020 and is expected to reach $12.61 billion by 2031, registering a CAGR of 15.79% during the forecast period 2021-2031.
The global constrained peptide drugs market is anticipated to be valued at $60.1 million in 2023 and is expected to reach $10,367.2 million by 2031, witnessing a CAGR of 90.37% during the forecast period 2023-2031.
The global nucleic acid therapeutics CDMO market was valued at $1,546.4 million in FY2020 and is estimated to reach $4,463.7 million by 2030.
The global market for microbiome therapeutics is predicted to grow at a CAGR of 25.64% over the forecast period of 2020-2030.
By volume, global NIPT market was 3.14 million units in 2019 and is expected to reach 23.58 million units by 2030.
The Global Next-Generation Biomanufacturing Market Report by BIS Research projects the market to grow at a significant CAGR of 10% during the forecast period, 2019-2029.
The global biologics drug discovery market was estimated to be $8.9 billion in 2016 and is estimated to grow over $22.7 billion by 2025. Introduction of targeted therapies coupled with rising adoption of patient centric personalized medicine is expected to fuel the demand for biologics drugs in the future.
A PHP Error was encountered
Severity: Warning
Message: Invalid argument supplied for foreach()
Filename: web/catdetailsnew.php
Line Number: 781
I would like to extend our appreciation for your support in finalizing the report according to our precise needs and prerequisites. I am also impressed by the timely completion of all aspects of dealing with us as your esteemed client. I look forward to continue our professional relations in the future.
Manager-Strategy & Business DevelopmentICL Industrial Products
“I found the content quite interesting and insightful. It has provided us with some important information”
Strategic Insights COE ManagerJapan Tobacco International
I appreciate the extra effort that team BIS took to cater to our specific requirements, moreover, their response time and adaptability is at par with my expectation.
CEO & ChairmanTEKNA Plasma Systems
“BIS research has been a great support to our strategic investigation in the field of thermoplastic composite. BIS did manage to bring together a clear picture on a global level, supported by examples and references and they delivered an accurate evaluation of the current market size and potential in the coming years in line with our expectations. I warmly recommend them.”
VPFuture Business and Innovation